Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
ACS Medicinal Chemistry Letters|March 16, 2023
Controlling Ibrutinib's Conformations about Its Heterobiaryl Axis to Increase BTK SelectivitySean T Toenjes, Bahar S Heydari, Samuel T Albright, et al.Cancer Letters|June 29, 2024
Development of NR0B2 as a therapeutic target for the re-education of tumor associated myeloid cellsHashni Epa Vidana Gamage, Samuel T Albright, Amanda J Smith, et al.Biorxiv : the Preprint Server for Biology|August 30, 2023
Re-education of myeloid immune cells to reduce regulatory T cell expansion and impede breast cancer progressionHashni Epa Vidana Gamage, Sayyed Hamed Shahoei, Samuel T Albright, et al.Cancer Letters|June 22, 2024
NR0B2 re-educates myeloid immune cells to reduce regulatory T cell expansion and progression of breast and other solid tumorsHashni Epa Vidana Gamage, Sayyed Hamed Shahoei, Yu Wang, et al.Journal of Medicinal Chemistry|April 22, 2026
Rapid Optimization Enabled by Single-Molecule Tracking: Discovery of a Potent RUVBL1/2 Inhibitor to Evaluate the Targeting of MYC-Driven CancersLi Zheng, Eugene Park, Jason Lenihan, et al.Pageof 1